HomePACB • NASDAQ
add
Pacific Biosciences of California Inc
Nakaraang pagsara
$2.10
Sakop ng araw
$1.97 - $2.15
Sakop ng taon
$1.16 - $7.85
Market cap
575.11M USD
Average na Volume
8.53M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 39.97M | -28.23% |
Gastos sa pagpapatakbo | 69.21M | -24.66% |
Net na kita | -60.72M | 9.19% |
Net profit margin | -151.94 | -26.54% |
Kita sa bawat share | -0.17 | 37.04% |
EBITDA | -44.96M | 35.71% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 471.15M | -38.64% |
Kabuuang asset | 1.45B | -23.62% |
Kabuuang sagutin | 996.93M | -12.13% |
Kabuuang equity | 453.12M | — |
Natitirang share | 273.86M | — |
Presyo para makapag-book | 1.27 | — |
Return on assets | -9.46% | — |
Return on capital | -10.03% | — |
Cash Flow
Net change in cash
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -60.72M | 9.19% |
Cash mula sa mga operasyon | -45.46M | 30.25% |
Cash mula sa pag-invest | 23.06M | -90.48% |
Cash mula sa financing | 812.00K | 203.97% |
Net change in cash | -21.59M | -112.24% |
Malayang cash flow | -13.40M | 88.84% |
Tungkol
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
Itinatag
2004
Headquarters
Website
Mga Empleyado
796